ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,964 | -59.5% | 778 | -52.0% | 0.00% | – |
| Q2 2023 | $34,470 | +85.0% | 1,620 | +51.4% | 0.00% | – |
| Q1 2023 | $18,635 | -31.0% | 1,070 | -18.6% | 0.00% | – |
| Q4 2022 | $27,000 | +3.8% | 1,315 | +31.5% | 0.00% | – |
| Q3 2022 | $26,000 | -3.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $27,000 | -97.2% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $971,000 | +2211.9% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $42,000 | -4.5% | 1,000 | -20.3% | 0.00% | – |
| Q3 2021 | $44,000 | +25.7% | 1,255 | 0.0% | 0.00% | – |
| Q2 2021 | $35,000 | -5.4% | 1,255 | 0.0% | 0.00% | – |
| Q1 2021 | $37,000 | -22.9% | 1,255 | -32.4% | 0.00% | – |
| Q4 2020 | $48,000 | +242.9% | 1,856 | +121.0% | 0.00% | – |
| Q3 2020 | $14,000 | -30.0% | 840 | +6.3% | 0.00% | – |
| Q2 2020 | $20,000 | +81.8% | 790 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | – | 790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |